CAR T-Cell, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
Authors :
Caron A Jacobson & Parth S. Shah
Date of Publication: 10/2023
In this issue of Hematology/Oncology Clinics, guest editors Drs. Caron A. Jacobson and Parth S. Shah bring their considerable expertise to the topic of CAR T-Cell Therapy. Top experts in the field discuss the multiple ways CAR T-cell therapy can be u ...view more
In this issue of Hematology/Oncology Clinics, guest editors Drs. Caron A. Jacobson and Parth S. Shah bring their considerable expertise to the topic of CAR T-Cell Therapy. Top experts in the field discuss the multiple ways CAR T-cell therapy can be used to help fight a variety of cancers, such as diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, multiple myeloma, and B-cell acute lymphoblastic leukemia (ALL).
In this issue of Hematology/Oncology Clinics, guest editors Drs. Caron A. Jacobson and Parth S. Shah bring their considerable expertise to the topic of CAR T-Cell Therapy. Top experts in the field discuss the multiple ways CAR T-cell therapy can be used to help fight a variety of cancers, such as diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, multiple myeloma, and B-cell acute lymphoblastic leukemia (ALL).
Key Features
Contains 12 practice-oriented topics including CAR T-cells in aggressive B-cell lymphomas; CAR T-cells in multiple myeloma; CAR T-cells in AML; mechanisms of resistance of CAR T-cell therapy; the role of CAR T-cell therapy in the era of bispecific antibodies; and more.
Provides in-depth clinical reviews on CAR T-cell therapy, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Caron A Jacobson, MD, Harvard Medical School and Parth S. Shah, MD, Assistant Professor of Medicine, Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth, Director of Genome Informatics, Dartmouth-Hitchcock, Transplant and CAR-T, Dana-Farber Cancer Institute
Bring it with you - The Bookshelf app allows you to access books on your laptop, tablet or mobile, so your ebooks go where ever you are - online or offline.
Take notes - Highlight, bookmark and take notes and highlights automatically stay in sync no matter where you make them.
Listen to eBooks - When you need to go screenless, the Text-to-speech tool will read your book aloud.
Powerful search - The searching capabilities allow you to search keywords through all your eBooks, the entire Bookshelf Library and well as on Wikipedia.
Ecological - Manage your environmental impact with paperless books.
How to read your VitalSource eBooks
Purchase your VitalSource eBook on the Elsevier Health site
https://www.uk.elsevierhealth.com/car-t-cell-an-issue-of-hematologyoncology-clinics-of-north-america-9780443183003.html306209CAR T-Cell, An Issue of Hematology/Oncology Clinics of North Americahttps://www.uk.elsevierhealth.com/media/catalog/product/9/7/9780443183003_7.jpg64.4985.99GBPInStock/Medicine and Surgery/Haematology/Books/Clinics Review Articles100335255039561283917453100005145120In this issue of Hematology/Oncology Clinics, guest editors Drs. Caron A. Jacobson and Parth S. Shah bring their considerable expertise to the topic of CAR T-Cell Therapy. Top experts in the field discuss the multiple ways CAR T-cell therapy can be used to help fight a variety of cancers, such as diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, multiple myeloma, and B-cell acute lymphoblastic leukemia (ALL). In this issue of Hematology/Oncology Clinics, guest editors Drs. Caron A. Jacobson and Parth S. Shah bring their considerable expertise to the topic of CAR T-Cell Therapy. Top experts in the field discuss the multiple ways CAR T-cell therapy can be used to help fight a variety of cancers, such as diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, multiple myeloma, and B-cell acute lymphoblastic leukemia (ALL). 00add-to-cart97804431830032023ProfessionalEdited by Caron A Jacobson, MD and Parth S. Shah, MD20231Book152w x 229h (6.00" x 9.00")Elsevier24013 Oct 2023PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSEdited by <STRONG>Caron A Jacobson</STRONG>, MD, Harvard Medical School and <STRONG>Parth S. Shah</STRONG>, MD, Assistant Professor of Medicine, Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth, Director of Genome Informatics, Dartmouth-Hitchcock, Transplant and CAR-T, Dana-Farber Cancer InstituteClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
